252 related articles for article (PubMed ID: 23455314)
1. Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors.
Ogden KK; Traynelis SF
Mol Pharmacol; 2013 May; 83(5):1045-56. PubMed ID: 23455314
[TBL] [Abstract][Full Text] [Related]
2. Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of
Strong KL; Epplin MP; Ogden KK; Burger PB; Kaiser TM; Wilding TJ; Kusumoto H; Camp CR; Shaulsky G; Bhattacharya S; Perszyk RE; Menaldino DS; McDaniel MJ; Zhang J; Le P; Banke TG; Hansen KB; Huettner JE; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2021 Jan; 12(1):79-98. PubMed ID: 33326224
[No Abstract] [Full Text] [Related]
3. A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons.
Swanger SA; Vance KM; Acker TM; Zimmerman SS; DiRaddo JO; Myers SJ; Bundgaard C; Mosley CA; Summer SL; Menaldino DS; Jensen HS; Liotta DC; Traynelis SF
ACS Chem Neurosci; 2018 Feb; 9(2):306-319. PubMed ID: 29043770
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor channel gating control by the pre-M1 helix.
McDaniel MJ; Ogden KK; Kell SA; Burger PB; Liotta DC; Traynelis SF
J Gen Physiol; 2020 Apr; 152(4):. PubMed ID: 32221541
[TBL] [Abstract][Full Text] [Related]
6. The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca
Perszyk RE; Zheng Z; Banke TG; Zhang J; Xie L; McDaniel MJ; Katzman BM; Pelly SC; Yuan H; Liotta DC; Traynelis SF
Mol Pharmacol; 2021 May; 99(5):399-411. PubMed ID: 33688039
[TBL] [Abstract][Full Text] [Related]
7. Specific sites within the ligand-binding domain and ion channel linkers modulate NMDA receptor gating.
Talukder I; Borker P; Wollmuth LP
J Neurosci; 2010 Sep; 30(35):11792-804. PubMed ID: 20810899
[TBL] [Abstract][Full Text] [Related]
8. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
9. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening.
Talukder I; Wollmuth LP
J Gen Physiol; 2011 Aug; 138(2):179-94. PubMed ID: 21746848
[TBL] [Abstract][Full Text] [Related]
10. A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors.
Mullasseril P; Hansen KB; Vance KM; Ogden KK; Yuan H; Kurtkaya NL; Santangelo R; Orr AG; Le P; Vellano KM; Liotta DC; Traynelis SF
Nat Commun; 2010 Oct; 1():90. PubMed ID: 20981015
[TBL] [Abstract][Full Text] [Related]
11. Conserved structural and functional control of N-methyl-D-aspartate receptor gating by transmembrane domain M3.
Yuan H; Erreger K; Dravid SM; Traynelis SF
J Biol Chem; 2005 Aug; 280(33):29708-16. PubMed ID: 15970596
[TBL] [Abstract][Full Text] [Related]
12. A novel family of negative and positive allosteric modulators of NMDA receptors.
Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
[TBL] [Abstract][Full Text] [Related]
13. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors.
Kloda A; Clements JD; Lewis RJ; Adams DJ
Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832
[TBL] [Abstract][Full Text] [Related]
14. The Bioactive Protein-Ligand Conformation of GluN2C-Selective Positive Allosteric Modulators Bound to the NMDA Receptor.
Kaiser TM; Kell SA; Kusumoto H; Shaulsky G; Bhattacharya S; Epplin MP; Strong KL; Miller EJ; Cox BD; Menaldino DS; Liotta DC; Traynelis SF; Burger PB
Mol Pharmacol; 2018 Feb; 93(2):141-156. PubMed ID: 29242355
[No Abstract] [Full Text] [Related]
15. A structurally derived model of subunit-dependent NMDA receptor function.
Gibb AJ; Ogden KK; McDaniel MJ; Vance KM; Kell SA; Butch C; Burger P; Liotta DC; Traynelis SF
J Physiol; 2018 Sep; 596(17):4057-4089. PubMed ID: 29917241
[TBL] [Abstract][Full Text] [Related]
16. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
Wilding TJ; Lopez MN; Huettner JE
J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
[TBL] [Abstract][Full Text] [Related]
17. Subunit-specific contribution of pore-forming domains to NMDA receptor channel structure and gating.
Sobolevsky AI; Prodromou ML; Yelshansky MV; Wollmuth LP
J Gen Physiol; 2007 Jun; 129(6):509-25. PubMed ID: 17504910
[TBL] [Abstract][Full Text] [Related]
18. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
[TBL] [Abstract][Full Text] [Related]
19. Biased modulators of NMDA receptors control channel opening and ion selectivity.
Perszyk RE; Swanger SA; Shelley C; Khatri A; Fernandez-Cuervo G; Epplin MP; Zhang J; Le P; Bülow P; Garnier-Amblard E; Gangireddy PKR; Bassell GJ; Yuan H; Menaldino DS; Liotta DC; Liebeskind LS; Traynelis SF
Nat Chem Biol; 2020 Feb; 16(2):188-196. PubMed ID: 31959964
[TBL] [Abstract][Full Text] [Related]
20. A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain.
Wang TM; Brown BM; Deng L; Sellers BD; Lupardus PJ; Wallweber HJA; Gustafson A; Wong E; Volgraf M; Schwarz JB; Hackos DH; Hanson JE
Neuropharmacology; 2017 Jul; 121():204-218. PubMed ID: 28457974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
